Clinical Trial Update: Prevention of Depression With Omega-3 Fatty Acids in Chronic Carriers of Hepatitis C Treated With Interferon Alpha. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating whether omega-3 fatty acids can prevent depression in chronic hepatitis C patients treated with interferon alpha.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Interferon-alpha (interferon alpha)
• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Bnai Zion Medical Center | Conditions: Chronic Hepatitis C | Phase 2 | Status: UNKNOWN